Ads
related to: Acute Myeloid Leukemia- Treatment Option
Visit The Physician Website To
Learn More About This Treatment.
- $0 Co-Pay Information
Patients With Private Insurance
Could Save On Their Prescription.
- View Patient Profiles
Patients Experience Treatment
Intolerance & Suboptimal Responses
- Safety Profile
Physicians, See Important Safety
Information About This Treatment.
- Mechanism Of Action
Learn How To Treat Patients
With Ph+ CML-CP Today.
- Efficacy Information
Physicians, See How This Treatment
May Help Your Patients Today.
- Treatment Option
Search results
Syndax Announces Completion of Enrollment in AUGMENT-101 Pivotal Trial Cohort of Patients with...
FOX 4 Kansas City· 3 hours agoTopline data is expected in the fourth quarter of 2024 and could support a supplemental New Drug...
Celebrity trainer Gunnar Peterson reveals his 4-year-old has cancer after 'typical kid' symptoms
TODAY via Yahoo News· 9 hours agoCelebrity trainer Gunnar Peterson shared that his his daughter has cancer. In an Instagram post with...
Celeb Trainer Gunnar Peterson Shares 4-Year-Old's Cancer Diagnosis
E! News via Yahoo News· 20 hours agoAfter celebrity trainer Gunnar Peterson shared 4-year-old daughter Monroe was diagnosed with acute ...
Celeb Trainer Gunnar Peterson's 4-Year-Old Daughter Is Battling Cancer
Us Weekly via AOL· 18 hours agoThe disease starts in the bone marrow and can spread to other parts of the body, like the lymph...
ABT199/Venetoclax synergism with thiotepa in acute myeloid leukemia (AML) cells
Medical Xpress· 3 days agoA new research paper titled "ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells" has been published in Oncotarget.
Earnings call: Aptose Biosciences outlines Tuspetinib's AML treatment potential By Investing.com
Investing.com· 22 hours agoThe company highlighted the potential of Tuspetinib as a core component in a triplet therapy for the...
Aptose Biosciences target cut, maintains buy rating on new drug development By Investing.com
Investing.com· 17 hours agoThe adjustment comes as Aptose Biosciences shifts its development focus towards a new drug...
Research points to an immunotherapy to overcome resistant leukemia
Medical Xpress· 7 days agoAcute myeloid leukemia (AML) is an aggressive form of blood cancer. It is caused by mutations in a large number of genes that are acquired ...
Q4 2023 GlycoMimetics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 8 hours agoThis is a significant milestone that can fundamentally impact our company's trajectory while potentially helping patients affected with relapsed and refractory acute
Cantargia Reports Progress Towards Start of DOD-Sponsored Clinical Trial of Nadunolimab in Leukemia
Digital Journal· 1 day ago:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today reported on the progress in the upcoming phase Ib/IIa clinical trial investigating nadunolimab in up to 40 patients with
Ads
related to: Acute Myeloid Leukemia